Ixempra (ixabepilone)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ixempra (ixabepilone), covering 2011-10-19 to 2011-10-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma [Phase 1]